Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzocaine + lidocaine + epinephrine is a combination anesthetic regimen evaluated by the David Grant U.S. Air Force Medical Center for the management of procedural pain during cosmetic facial filler injections (e.g., Juvederm XC). The protocol involves the topical application of 20% benzocaine gel as a pre-treatment, followed by a nerve block injection of 2% lidocaine with 1:100,000 epinephrine. Benzocaine and lidocaine are local anesthetics that inhibit nerve conduction by blocking voltage-gated sodium channels. Epinephrine is included as a vasoconstrictor to prolong the local anesthetic effect and minimize systemic absorption. This specific combination was studied in a Phase 4 clinical trial (NCT02154399) to compare its efficacy against topical 4% Topicaine gel in patients undergoing lip or labiomental fold augmentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzocaine + lidocaine + epinephrine.